Similarly, breast cancers with PD/SD had higher percentage of CD44+/CD24−cancer cells than those with PR/CR (35.0%±9.13% vs. 1.56±0.33%, p<0.001, Figure 2B). This evidence concerns the gene CD44 and breast cancer.